Exela Pharma Sciences LLC is recalling 23,775 vials of Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) because some vials may be 'short filled,' meaning they contain less medication than the labeled amount. This recall affects one specific lot of single-dose vials distributed nationwide and in Puerto Rico. Because this is a prescription medication used in clinical settings, a short fill could lead to a patient receiving an incorrect dose of potassium. Consumers should check their supply for lot number P0000471 and contact their healthcare provider or pharmacist for further guidance.
A short-fill vial contains less than the intended volume of medication, which can lead to the administration of an under-dose to the patient. For potassium acetate, an under-dose may fail to properly treat or prevent potassium deficiency (hypokalemia), which is critical for heart and muscle function.
Healthcare provider consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.